Federal Register / Vol. 65, No. 12 / Wednesday, January 19, 2000 / Notices 2975

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated January 6, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1148 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Aging; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Aging Special Emphasis Panel, Cellular

Senescence and Control of Cell Proliferation.

Date: February 4, 2000.

Time: 12:00 PM to 2:30 PM.

Agenda: To review and evaluate grant

applications.

Place: 7201 Wisconsin Avenue, Bethesda,

MD 20892, (Telephone Conference Call).

Contact Person: William A. Kachadorian,

PhD, Scientific Review Administrator, The

Bethesda Gateway Building, 7201 Wisconsin

Avenue/Suite 2c212, Bethesda, MD 20892,

(301) 496-9666.

Name of Committee: National Institute of

Aging Special Emphasis Panel, Nathan Shock

Centers of Excellence in Basic Biology of

Aging.

Date: February 21–23, 2000.

Time: 8:00 PM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: James P. Harwood, PhD,

Deputy Chief, The Bethesda Gateway

Building, 7201 Wisconsin Avenue/Suite

2C212, Bethesda, MD 20892, (301) 496-9666.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.866, Aging & Research,

National Institutes of Health, HHS)

Dated: January 7, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 1149 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

infectious Diseases; Notice of Meeting:

Chronic Fatigue Syndrome

Coordinating Committee

In accordance with section 10(a) of

the Federal Advisory Committee Act, as

amended (5 U.S.C., Appendix 2), the

National Institute of Allergy and

Infectious Disease (NIAID), National

Institutes of Health (NIH) announces the

following committee meeting.

Name: Chronic Fatigue Syndrome

Coordinating Committee (CFSCC).

Time and Date: Tuesday, February 8, 2000,

9:00 a.m.–5 p.m.

Place: Hubert H. Humphrey Building,

Room 800, 200 Independence Avenue, SW,

Washington, DC.

Status: Open to the public, limited only by

the space available. The meeting room will

accommodate approximately 100 people.

Notice: In the interest of security, the

Department has instituted stringent

procedures for entrance to the Hubert H.

Humphrey Building by non-government

employees. Thus, persons without a

government identification card will need to

provide a photo ID and must know the

subject and room number of the meeting in

order to be admitted into the building.

Visitors must use the Independence Avenue

entrance.

Purpose: The Committee is charged with

providing advice to the Secretary, the

Assistant Secretary for Health, and the

Commissioner, Social Security

Administration (SSA), to assure interagency

coordination and communication regarding

chronic fatigue syndrome (CFS) research and

other related issues; facilitating increased

Department of Health and Human Services

(HHS) and agency awareness of CFS research

and educational needs; developing

complementary research programs that

minimize overlap; identifying opportunities

for collaborative and/or coordinated efforts in

research and education; and developing

informed responses to constituency groups

regarding HHS and SSA efforts and progress.

Matters To Be Discussed: A report on

CDC’s CFS Scientific Review; and report on

NIH’s CFS consultation. Agenda items are

subject to change as priorities dictate.

Public Comments will be received at the

meeting for a total of not more than 60

minutes. Persons wishing to make oral

comments either in person or via a video

should notify the contact person listed below

no later than close of business on January 26,

2000. A lottery system will be utilized to

select speakers only if the number of requests

exceed the number of slots, and those

selected through this process will be notified

on January 26 or soon thereafter. If a selected

individual is unable to deliver their

testimony at the meeting or submit their

video prior to the meeting, their testimony

slot will be filed on a first come first served

basis on the day of the meeting following an

announcement soliciting substitutes by the

Chair. Testimony presented to the Committee

on the day of the meeting will become part

of the public record. Due to the time

available, public comments will be limited to

five minutes per person. Copies of any

written comments should be provided to the

Executive Secretary at the meeting; in

addition, please provide at least 50 copies for

distribution to Committee members and

attendees.

Contact Person for More Information:

Louise Garnett, Program Coordinator,

Division of Microbiology and Infectious

Diseases, NIAID, NIH, 6700B Rockledge

Drive, Room 3266, Bethesda, MD 20892,

telephone 301–496–1884, fax 301–480–4528.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: January 5, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–1150 Filed 1–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Arthritis and Musculoskeletal

and Skin Diseases Advisory Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning